Spago Nanomedical: Valuation, Funding & Investors
Spago Nanomedical is a biotechnology company focused on developing innovative nanomedical solutions for cancer treatment. The company is advancing Tumorad, a radionuclide therapy leveraging its unique nanomaterial platform for effective delivery of radiation to tumors.
Leadership & Board
- Current Number of Employees
- 18
- Current LinkedIn Followers
- 1,592
Latest Estimated Valuation
- Total Amount Raised
- $25M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $25M
- Latest Funding Round
- Investment
Employee Trend
Spago Nanomedical had 18 employees as of October 26, 2026. The number of employees increased by 0 (0.00%) week-over-week.
18Latest Employee Count
0(0.00%)Week-Over-Week Change
Social Trend
Spago Nanomedical had 1,592 followers as of October 26, 2026. The number of followers increased by 6 (0.38%) week-over-week.
1,592Latest Followers Count
6(0.38%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Oct 29, 2025 | Investment | $25.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Mikael Lönn | Investment |
| Cidro Förvaltning AB | Investment |
| Eva Redhe | Investment |
| Tiel Ridderstad | Investment |
| Filippa Lindström | Investment |
| Andreas Bunge | Investment |
| Maria Rankka | Investment |
Similar Companies
A snapshot of private companies similar to Spago Nanomedical, helping you discover and navigate related company profiles.
Related News and Analysis
